These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10234655)

  • 1. Immunocytochemical and molecular strategies for the detection of micrometastases in patients with solid epithelial tumours: a review.
    Pantel K; Ahr A
    Nucl Med Commun; 1998 Jun; 19(6):521-7. PubMed ID: 10234655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and clinical significance of occult tumour cells in colorectal cancer.
    Tsavellas G; Patel H; Allen-Mersh TG
    Br J Surg; 2001 Oct; 88(10):1307-20. PubMed ID: 11578283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of minimal disease in patients with solid tumors.
    Pantel K
    J Hematother; 1996 Aug; 5(4):359-67. PubMed ID: 8877711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and characterization of residual disease in breast cancer.
    Pantel K; Felber E; Schlimok G
    J Hematother; 1994; 3(4):315-22. PubMed ID: 7735827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and clinical relevance of micrometastatic cancer cells.
    Pantel K; von Knebel Doeberitz M
    Curr Opin Oncol; 2000 Jan; 12(1):95-101. PubMed ID: 10687736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.
    Partridge M; Li SR; Pateromichelakis S; Francis R; Phillips E; Huang XH; Tesfa-Selase F; Langdon JD
    Clin Cancer Res; 2000 Jul; 6(7):2718-25. PubMed ID: 10914716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular tools in the detection of micrometastatic cancer cells--technical aspects and clinical relevance.
    von Knebel Doeberitz M; Weitz J; Koch M; Lacroix J; Schrödel A; Herfarth C
    Recent Results Cancer Res; 2001; 158():181-6. PubMed ID: 11092045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical aspects of minimal residual disease detection in carcinoma patients.
    Lacroix J; Doeberitz MK
    Semin Surg Oncol; 2001 Jun; 20(4):252-64. PubMed ID: 11747266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
    von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
    Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Minimal residual disease in breast cancer: detection and clinical relevance].
    Pantel K; Wölfle U
    Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of micrometastatic cancer cells.
    Pantel K; Hosch SB
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):18S-21S. PubMed ID: 11599890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of nonmelanoma skin cancer micrometastases in lymph nodes by using reverse transcriptase-polymerase chain reaction for keratin 19 mRNA.
    Kamiya M; Ichiki Y; Kamiya H; Yamamoto A; Kitajima Y
    Br J Dermatol; 2003 Nov; 149(5):998-1005. PubMed ID: 14632805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of micrometastatic bone marrow involvement.
    Braun S; Pantel K
    Breast Cancer Res Treat; 1998; 52(1-3):201-16. PubMed ID: 10066083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview.
    Zippelius A; Pantel K
    Ann N Y Acad Sci; 2000 Apr; 906():110-23. PubMed ID: 10818606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
    Gazquez C; Ribal MJ; Marín-Aguilera M; Kayed H; Fernández PL; Mengual L; Alcaraz A
    BJU Int; 2012 Nov; 110(9):1310-6. PubMed ID: 22416928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolated tumor cells in primary malignant liver tumors].
    Tannapfel A; Geissler F; Witzigmann H; Wittekind C
    Zentralbl Chir; 2000; 125(7):602-5. PubMed ID: 10960969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterisation of minimal residual disease in solid tumors.
    Pantel K; Otte M
    Acta Med Austriaca Suppl; 2000; 52():8-12. PubMed ID: 11261279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow micrometastases and gastrointestinal cancer detection and significance.
    Maguire D; O'Sullivan GC; Collins JK; Morgan J; Shanahan F
    Am J Gastroenterol; 2000 Jul; 95(7):1644-51. PubMed ID: 10925963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.